On Thursday, April 19, 2012, Moody's Investors Service held a teleconference to discuss the 2012 outlook for global pharmaceutical companies.
The discussion was led by:
Michael Levesque, Senior Vice President
Marie Fischer-Sabatie, Vice President-Senior Credit Officer
The following topics were discussed:
- Patent cliff pressures expected to peak in 2012
- Pipelines still insufficient, but inflexion point reached
- Ongoing pressures from healthcare reforms
- Biosimilars: progress towards regulatory pathways
- M&A to remain on the agenda and share buybacks gaining momentum
For questions regarding this event please contact our Client Service and Support Team:
Americas +1.212.553.1653 Asia Pacific +852.3551.3077
EMEA +44.20.7772.5454 Japan +81.3.5408.4100